课题基金 / 基金详情

The Role of Ceramides in the Pancreatic Beta Cell

The Role of Ceramides in the Pancreatic Beta Cell
神经酰胺在胰腺β细胞中的作用
批准号:
10592412
负责人:
WILLIAM L HOLLAND
金额:
$55.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31
关键词:
Adipose tissueAnabolismAnimal ModelApoptosisApoptoticAutoimmuneBeta CellBiological AssayBiological MarkersBiotechnologyBlood GlucoseCarbohydratesCell SurvivalCell physiologyCellsCeramidesCessation of lifeConsumptionCytoprotectionDataDetergentsDevelopmentDiabetes MellitusDiseaseDrug KineticsEnzymesFailureFamilyFatty AcidsGenesGlucoseGrowthHormonesHumanHyperglycemiaImmunologicsImpairmentInbred NOD MiceInduction of ApoptosisInflammationInflammatoryInsulinIntestinal permeabilityIslets of LangerhansIsotopesLinkLipidsLiverMacronutrients NutritionMembraneMetabolicMetabolismMitochondriaModelingMolecularMusMuscleNatural regenerationNon-Insulin-Dependent Diabetes MellitusNutrientNutritionalOrganismPancreasPathway interactionsPharmaceutical PreparationsPharmacodynamicsPhenotypePopulationProductionPropertyRattusRepressionRodentRodent ModelRoleSafetySaturated Fatty AcidsScienceSignal TransductionSkeletal MuscleSolubilitySphingolipidsStressStructure of beta Cell of isletTestingTherapeuticTissuesTransgenic MiceTreatment EfficacyWorkaqueousbiological adaptation to stresscell regenerationcytokinedetection of nutrientdiabeticdihydroceramidedihydroceramide desaturasedrug candidateefficacy testingimpaired glucose toleranceimprovedin vivoinhibitorinsulin secretionisletislet xenograftmetabolomicsmouse modelnovelnovel therapeuticsoverexpressionpeptide hormonepharmacologicpi bondpreservationpreventsaturated fatsingle cell sequencingsmall molecule inhibitortheoriestherapeutic evaluationtherapeutic targettooltype I and type II diabetesuptake

项目摘要

项目成果

WILLIAM L HOLLAND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY This proposal explores the hypothesis that sphingolipids such as ceramides serve as common, cell-autonomous signals that impair beta cell function and contribute to the development of type 1 and type 2 diabetes. The idea is predicated upon data presented herein showing that the administration of a pharmacological inhibitor of ceramide biosynthesis to rodents preserves the beta cell and prevents the development of both forms of the disease (i.e. in Zucker Diabetic Fatty rats as well as Non-Obese Diabetic mice). The theory is further supported by studies in human and mouse islets implicating ceramides as intermediates linking saturated fatty acids and inflammatory cytokines to the impairment of insulin secretion, mitochondrial function, and beta cell survival. We will evaluate this hypothesized role for ceramides and its metabolites in the pancreatic islet through the following aims: · First, we will study new mouse models allowing for the conditional, beta cell-specific modulation of genes involved in ceramide synthesis or degradation, allowing us to determine whether the lipids are either (a) necessary or (b) sufficient for beta cell failure and the onset of frank hyperglycemia. · Second, we will test the efficacy of a new class of ceramide synthesis inhibitors targeting dihydroceramide desaturase-1 as therapeutics that improve insulin secretion and prevent type 1 or type 2 diabetes in rodents. · Third, we will determine the mechanisms through which ceramides impair the function of mouse and human islets. We will test a hypothesized role for ceramides as drivers of metabolic reprogramming using state-of-the-art metabolic tracing, mitochondrial phenotyping, and cell function assays. Findings obtained from these studies could uncover new nutrient-sensing and/or inflammatory mechanisms that modulate islet function, survival and growth. Moreover, the translational component of this work could lead to the development of new therapeutic alternatives for preventing or treating diabetes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1172/jci175799
发表时间: 2023-12-15
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Tatum, Sean M., Holland, William L.]
通讯作者: Holland, William L.
The Role of Ceramides in the Pancreatic Beta Cell
  • 批准号:
    10467400
  • 项目类别:
  • 资助金额:
    $56.22万
  • 财政年份:
    2022
  • 负责人:
    WILLIAM L HOLLAND
  • 依托单位:
Lipid Sensing in Pancreatic Alpha Cells
  • 批准号:
    9444831
  • 项目类别:
  • 资助金额:
    $40.5万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM L HOLLAND
  • 依托单位:
Liver-islet and intra-islet cross talk in alpha cell hyperplasia and beta cell regeneration
  • 批准号:
    10540191
  • 项目类别:
  • 资助金额:
    $45.48万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM L HOLLAND
  • 依托单位:
Liver-islet and intra-islet cross talk in alpha cell hyperplasia and beta cell regeneration
  • 批准号:
    10654025
  • 项目类别:
  • 资助金额:
    $45.63万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM L HOLLAND
  • 依托单位:
海外基金